| | |

Tag search: "Sanofi"

Promoting health through the life course

Regulator links Sanofi epilepsy drug to child deformities

Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy and bipolar disorder known as valproate between 1967 and 2016, France’s drug regulator said

April 20, 2017
Reuters, Financial Times
April 21, 2017
The Guardian
April 20, 2017

Preparedness, surveillance and response

Chelsea Clinton praises Sanders for Zika op-ed

Senator Bernie Sanders heavily criticized Sanofi in an NYT Opinion Editorial, noting the firm has already received $43m from the government to develop a Zika vaccine and it is now expected to receive a further $130m. Senator Sanders said ‘if Trump approves this deal, Sanofi will be able to charge whatever astronomical price it likes for its vaccine.’ Chelsea Clinton praised Bernie Sanders’ article in a tweet

March 11, 2017
The Hill
March 13, 2017
Huffington Post
March 10, 2017
New York Times
March 11, 2017
Washington Examiner

Non communicable diseases

Novo Nordisk reveals results from real-world study of Tresiba drug

Danish diabetes drug maker Novo Nordisk presented its findings from the real-world study EU-TREAT at the American Diabetes Association`s 77th Scientific Sessions. "Switching to Tresiba provides significant reductions in blood glucose and lower rates of hypoglycaemia in a real-world settings," Novo Nordisk said. People with type 1 diabetes and type 2 diabetes experienced a significant reduction in HbA1c, a measure of long-term blood glucose levels, six months after switching to Tresiba from another basal insulin, primarily rival Sanofi`s Lantus (insulin glargine), and its own insulin Levemir (insulin detemir), in a real-world setting

June 10, 2017

OPPI to develop integrated disease management process

Speaking at the OPPI Sixth Healthcare Access Summit, Shailesh Ayyangar, President of OPPI and Managing Director of Sanofi India, said, “Collaborating with the government and other stakeholders at national, state and local levels, the summit endeavours to develop and expand an integrated disease management process broadly engaging with affected communities in the fight against non-communicable diseases.” “The good news is that we have therapies that can combat the non-communicable diseases and help patients live a full and normal life by strengthening patient self-management education; community-based supportive services and broad-based community mobilization,” said Ayyangar – this is needed given the scale of the issue and the rising costs of NCDs to the Indian healthcare system

June 9, 2017
Economic Times
June 11, 2017
Hindu Business Line

Health systems

Escaping Big Pharma’s Pricing With Patent-Free Drugs

The U.S. government funded research and development of a new vaccine against Zika, but the Army, which paid a French pharmaceutical manufacturer for its development, is planning to grant exclusive rights to the vaccine to the manufacturer, Sanofi Pasteur, along with paying Sanofi up to $173 million. Sanofi will be free to charge the U.S. American health care providers and patients any price it wishes. Although American tax dollars funded the vaccine, and the U.S. took the economic risks, history suggests that many Americans would not be able to afford it

July 18, 2017
New York Times

Sanofi rejects US Army request for ‘fair’ pricing for a Zika vaccine

Sanofi Pasteur has rejected a request from the US Army to set an affordable US price for a Zika vaccine that the company is developing with American taxpayer funds, prompting an angry response from Senator Bernie Sanders. For months, Sanders has pushed the Army to negotiate a more favourable arrangement with Sanofi, who has already received a $43m U.S. research grant. But Sanofi recently refused, according to an Army timeline of events

May 17, 2017
Stat News

Communicable diseases

Periodistas evalúan impacto de vacuna contra el dengue

Latin American journalists were invited by Sanofi Pasteur Labs to come and hear all about the findings of a dengue vaccine test in Parana, where each person was to have a jab every 6 months starting from last July. They reached 200,000 people in 30 districts, those most affected by dengue, however, there was little interest among people to get vaccinated and authorities had to go house to house to get people to do so in some instances. The vaccine really only reached middle and upper class people making the dose that much more expensive per person. There needs to be more agreement on pricing and more public education campaign support, so its effectiveness is not yet proven

May 23, 2017
La Nacion

WHO Approves World's First-Ever Dengue Vaccine

Known as the Dengvaxia, several countries have already licensed it: for example, Mexico, Brazil, El Salvador and the Philippines, but last weeks’ WHO approval is likely to spur a host of other developing nations to follow suit at a time when climate change and urbanization are putting increasing numbers of people at risk from mosquito-borne diseases

April 15, 2017

Prior exposure to dengue or West Nile could make Zika worse: report

A new study says that prior infection with West Nile of dengue, two viruses closely related to Zika, can make Zika symptoms worse. It raises a degree of concern about current or experimental dengue vaccines because they could inadvertently make Zika infection worse. The study authors suggested that companies consider combining a dengue and Zika vaccine to protect against both illnesses at the same time

March 30, 2017
March 31, 2017